Clinical Trial Results: A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in Adolescents [Phase 3]

View source ↗

Summary

Phase 3 multicenter trial evaluating safety and immunogenicity of a live-attenuated chikungunya vaccine in adolescents has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chikungunya

Snippet

Sponsor: Butantan Institute | Conditions: Chikungunya | Phase 3 | Status: COMPLETED | Results posted: 2026-06-04